TUBG1P

Across TCGA pan-cancer cohorts, TUBG1P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated TUBG1P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher TUBG1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TUBG1P expression acts as an unfavorable survival marker, although some lineages such as BLCA and BRCA show a favorable association.

MESO, BLCA, and LIHC are the cancer types where TUBG1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	All	0.274	0.508	<.001	121	view →
BLCA	DFS	Quartile	III,IV	0.528	0.334	.001	64	view →
LIHC	OS	Median	All	0.683	0.853	<.001	54	view →
UVM	DFS	Tertile	II,III,IV	0.359	0.703	.014	32	view →
BRCA	OS	Tertile	IV	0.888	0.363	.002	31	view →
PAAD	DFS	Median	II,III,IV	0.354	0.196	.006	27	view →
UCS	DFS	Quartile	III,IV	0.614	0.274	.019	18	view →
HNSC	OS	Median	III,IV	0.799	0.692	.015	17	view →
READ	OS	Tertile	All	1.000	0.806	.008	12	view →
ACC	OS	Quartile	IV	0.947	0.431	.017	10	view →
THCA	DFS	Median	IV	0.451	0.865	.002	6	view →
SKCM	DFS	Quartile	IV	0.828	0.078	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

TUBG1P–MESO (DFS)

Open the MESO breakdown →